----
All Shareholders
Shareholder Type
- Public and others42.58%
- VC/PE firms41.58%
- Individuals & Insiders7.47%
- Private companies4.58%
- Institutions3.80%
Major Shareholders
| Shareholder | |||||
|---|---|---|---|---|---|
OrbiMed Advisors LLC | 22.13% | 24.79M | -- | +24.79M | |
Eli Lilly Investment Consulting (Shanghai) Co., Ltd. | 10.58% | 11.86M | -- | +11.86M | |
SR One Capital Management, LP | 8.87% | 9.94M | -- | +9.94M | |
Li Zhen | 5.23% | 5.86M | -- | +5.86M | |
Bcls Fund III Investments, Lp | 4.58% | 5.13M | -- | +5.13M | |
TCG Crossover Management, LLC | 3.20% | 3.59M | -- | +3.59M | |
Rui ZhuChief Technology Officer | 2.24% | 2.51M | -- | +2.51M | |
T. Rowe Price Group, Inc. | 0.54% | 607.85K | -- | +607.85K | |
Vanguard Capital Management, LLC | 0.04% | 50.01K | -- | +50.01K | |
Columbia Management Investment Advisers, LLC | <0.01% | 8.52K | -- | +8.52K | |
Vanguard Portfolio Management, LLC | <0.01% | 402.00 | -- | +402.00 | |
A. MacLeodChief Scientific Officer | 0.00% | 0.00 | -- | +0 |
